acetyl l carnitine canada why banned L-Carnitine 500 mg Capsules Health Canada Safety Alert -

Diagnostic and Statistically Manual of Mental Disorders, 4th ed

Research published in peptide patent literature from Diagen indicates the arginate form can achieve oral bioavailability exceeding 90%, compared to less than 3% for the acetate form

Maintenance Benefits continue accruing during months three through six, though the rate of visible change typically slows compared to the dramatic improvements of weeks seven through twelve

Disclaimer: The neurology research discussed is based on preclinical or early investigational phase studies, including ongoing clinical research in neurological and neurodegenerative conditions